Phase I/II Gene Transfer Clinical Trial of rAAV9.CMV.hNAGLU for Mucopolysaccharidosis (MPS) IIIB
Phase of Trial: Phase I/II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs ABO-101 (Primary)
- Indications Mucopolysaccharidosis III
- Focus Adverse reactions; First in man; Therapeutic Use
- 20 Dec 2017 According to an Abeona Therapeutics media release, has been dosed in the trial, at Nationwide Children's Hospital, Columbus, Ohio.
- 10 Nov 2017 Last checked against ClinicalTrials.gov record.
- 16 Oct 2017 Status changed from not yet recruiting to recruiting.